Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards June 3, 2020 · by Aviatior · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. · https://www.nature.com/articles/s41467-020-16455-7 Share this:Share on TumblrTweetWhatsAppTelegramEmailPrintMorePocketLike this:Like Loading... Related